Dilon Technologies raised $9M in growth capital funding, led by JGB Management Inc., to support operational scaling and double-digit revenue growth.
Dilon Technologies raised $9M in growth capital funding, led by JGB Management Inc., to support operational scaling and double-digit revenue growth.
06/10/25, 8:06 AM
Location
newport newsMoney raised
$9 million
Industry
biotechnology
Investors
Jgb Management Inc.
Dilon Technologies, a Newport News, VA-based provider of medical devices for biosurgery and breast cancer treatment and diagnosis, raised $9M in growth capital funding. The round was led by JGB Management Inc. The company intends to use the funds to support its continued double-digit revenue growth and operational scaling. Led by CEO George Makhoul, Dilon Technologies develops and markets innovative technologies used in hemostasis and cancer detection.
Company Info
Location
701 mariners row, ste 200
newport news, virginia, united states
Additional Info
Dilon Technologies is a medical device manufacturer that focuses on products that assist in the fight against breast cancer. We have a strong medical device portfolio to include the Navigator System, a trusted brand and world-renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe, a groundbreaking technology for accurate microscopic margin assessment in breast cancer surgery, and the TrueView 100 Pro, a Specimen Radiography System (SRS) that uses advanced radiography and automated software to precisely identify tumor lesions in resected or biopsied breast tissue.